DK1922334T3 - Tumorassocierede peptider, der binder til humant leukocyt antigen (HLA) klasse I eller II molekyler og dertil hørende anti-cancervaccine - Google Patents
Tumorassocierede peptider, der binder til humant leukocyt antigen (HLA) klasse I eller II molekyler og dertil hørende anti-cancervaccineInfo
- Publication number
- DK1922334T3 DK1922334T3 DK06777167.5T DK06777167T DK1922334T3 DK 1922334 T3 DK1922334 T3 DK 1922334T3 DK 06777167 T DK06777167 T DK 06777167T DK 1922334 T3 DK1922334 T3 DK 1922334T3
- Authority
- DK
- Denmark
- Prior art keywords
- molecules
- tumour
- present
- relates
- hla
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05019255A EP1760089B1 (en) | 2005-09-05 | 2005-09-05 | Tumor-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules and related anti-cancer vaccine |
PCT/EP2006/008641 WO2007028573A1 (en) | 2005-09-05 | 2006-09-05 | Tumor-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1922334T3 true DK1922334T3 (da) | 2011-04-18 |
Family
ID=35149455
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05019255T DK1760089T3 (da) | 2005-09-05 | 2005-09-05 | Tumor-associeret peptides bindende til human leukocyte antigen (HLA) class I eller II molecules og relateret anti-cancer vaccine |
DK06777167.5T DK1922334T3 (da) | 2005-09-05 | 2006-09-05 | Tumorassocierede peptider, der binder til humant leukocyt antigen (HLA) klasse I eller II molekyler og dertil hørende anti-cancervaccine |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05019255T DK1760089T3 (da) | 2005-09-05 | 2005-09-05 | Tumor-associeret peptides bindende til human leukocyte antigen (HLA) class I eller II molecules og relateret anti-cancer vaccine |
Country Status (23)
Country | Link |
---|---|
US (1) | US20090274714A1 (da) |
EP (2) | EP1760089B1 (da) |
JP (1) | JP5132561B2 (da) |
KR (1) | KR101150663B1 (da) |
CN (1) | CN101287755B (da) |
AT (2) | ATE440107T1 (da) |
AU (1) | AU2006289289B2 (da) |
BR (1) | BRPI0615466A2 (da) |
CA (1) | CA2621414C (da) |
CY (2) | CY1110536T1 (da) |
DE (2) | DE602005016112D1 (da) |
DK (2) | DK1760089T3 (da) |
EA (1) | EA013466B1 (da) |
ES (2) | ES2330013T3 (da) |
HR (1) | HRP20110240T1 (da) |
NO (1) | NO20081690L (da) |
NZ (1) | NZ565956A (da) |
PL (2) | PL1760089T3 (da) |
PT (2) | PT1760089E (da) |
RS (1) | RS51893B (da) |
SI (2) | SI1760089T1 (da) |
UA (2) | UA97095C2 (da) |
WO (1) | WO2007028573A1 (da) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1806359E (pt) | 2005-09-05 | 2010-05-25 | Immatics Biotechnologies Gmbh | Peptídeos associados a tumor ligando promiscuamente às moléculas do antigénio de leucócitos humanos (hla) da classe ii |
US20090004213A1 (en) | 2007-03-26 | 2009-01-01 | Immatics Biotechnologies Gmbh | Combination therapy using active immunotherapy |
ES2321680B1 (es) * | 2007-04-26 | 2010-03-05 | Fundacion Para La Investigacion Biosanitaria De Andalucia Oriental - Alejandro Otero (Fibao) | Restauracion de las moleculas hla de clase i mediante terapia genica empleando vectores adenovirales portando el gen de la beta 2-microglobulina. |
PT2183361E (pt) | 2007-07-27 | 2015-09-11 | Immatics Biotechnologies Gmbh | Nova imunoterapia para tumores neuronais e cerebrais |
US7994276B2 (en) * | 2007-07-27 | 2011-08-09 | Immatics Biotechnologies Gmbh | Composition of tumour-associated peptides and related anti-cancer vaccine |
NZ582822A (en) | 2007-07-27 | 2012-06-29 | Immatics Biotechnologies Gmbh | Novel immunogenic epitopes for immunotherapy |
CY1112212T1 (el) * | 2008-04-24 | 2015-12-09 | Immatics Biotechnologies Gmbh | Νεα σκευασματα πεπτιδιων που σχετιζονται με ογκους τα οποια συνδεονται σε μορια του αντιγονου ανθρωπινων λευκοκυτταρων (hla) ταξης i ή ii για εμβολια |
DE602008000891D1 (de) | 2008-04-30 | 2010-05-12 | Immatics Biotechnologies Gmbh | Neuartige Formulierungen von Tumor-assoziierten Peptiden, welche an menschliche Leukozytenantigene der Klasse I oder II für Impfungen binden |
HUE024541T2 (hu) | 2008-05-14 | 2016-01-28 | Immatics Biotechnologies Gmbh | Szurvivinbõl és neurocanból származó új és hatásos II-es osztályú MHC peptidek |
AU2016204707B2 (en) * | 2008-10-01 | 2018-02-22 | Immatics Biotechnologies Gmbh | Novel immunotherapy against several tumors including neuronal and brain tumors |
ES2536465T3 (es) * | 2008-10-01 | 2015-05-25 | Immatics Biotechnologies Gmbh | Composición de péptidos tumor-asociados y relacionados con la vacuna contra el cáncer para el tratamiento de glioblastoma (GBM) y otros cánceres |
GB201004575D0 (en) * | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers |
GB201004551D0 (en) * | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer |
GB201006360D0 (en) * | 2010-04-16 | 2010-06-02 | Immatics Biotechnologies Gmbh | Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development |
GB201009222D0 (en) | 2010-06-02 | 2010-07-21 | Immatics Biotechnologies Gmbh | Improved cancer therapy based on tumour associated antigens derived from cyclin D1 |
DK2646546T3 (da) * | 2010-12-02 | 2018-08-06 | Oncotherapy Science Inc | Tomm34-peptider og vacciner, der indeholder disse |
AU2012279923B2 (en) * | 2011-07-05 | 2017-03-09 | Cadila Pharmaceuticals Limited | Cancer antigen |
MY170949A (en) * | 2011-07-11 | 2019-09-20 | Cancer Res Initiatives Foundation | A peptide capable of binding with a human leukocyte antigen (hla) molecule, a cancer vaccine derived from said peptide and use of said cancer vaccine |
WO2014004609A2 (en) | 2012-06-27 | 2014-01-03 | University Of Medicine & Dentistry Of New Jersey | Rapid assays for t-cell activation by rna measurements using flow cytometry |
US20140017267A1 (en) * | 2012-07-13 | 2014-01-16 | Matthias W Rath | Metalloproteinase oligopeptides and their therapeutic use |
TWI775117B (zh) * | 2013-08-05 | 2022-08-21 | 德商伊瑪提克斯生物科技有限公司 | 新穎肽類,細胞及其用於治療多種腫瘤的用途,其製造方法及包含其等之醫藥組成物(二) |
AU2014363643B2 (en) | 2013-12-09 | 2019-01-03 | Targovax Solutions AS | A peptide mixture |
GB201501017D0 (en) * | 2014-12-23 | 2015-03-04 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers |
MA48487B1 (fr) | 2014-12-23 | 2021-11-30 | Immatics Biotechnologies Gmbh | Nouveaux peptides et combinaison de peptides à utiliser dans l'immunothérapie contre le carcinome hépatocellulaire (hcc) et d'autres cancers |
TWI755157B (zh) | 2015-03-17 | 2022-02-11 | 德商英麥提克生物技術股份有限公司 | 用於抗胰臟癌與其他癌症的免疫治療的新穎胜肽及胜肽的組合 |
GB201504502D0 (en) * | 2015-03-17 | 2015-04-29 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers |
KR20220167337A (ko) | 2015-03-27 | 2022-12-20 | 이매틱스 바이오테크놀로지스 게엠베하 | 다양한 종양에 대한 면역요법에서의 사용을 위한 펩티드 및 펩티드의 조합 |
GB201505305D0 (en) | 2015-03-27 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel Peptides and combination of peptides for use in immunotherapy against various tumors |
GB201505585D0 (en) * | 2015-03-31 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers |
GB201507030D0 (en) * | 2015-04-24 | 2015-06-10 | Immatics Biotechnologies Gmbh | Immunotherapy against lung cancers, in particular NSCLC |
GB201510771D0 (en) | 2015-06-19 | 2015-08-05 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer |
CR20200525A (es) * | 2015-06-19 | 2020-12-23 | Immatics Biotechnologies Gmbh | NUEVOS PÉPTIDOS Y NUEVAS COMBINACIONES DE PÉPTIDOS PARA EL USO EN LA INMUNOTERAPIA Y MÉTODOS PARA CREAR SOPORTES PARA EL USO CONTRA EL CÁNCER DE PÁNCREAS Y OTROS TIPOS DE CÁNCER (Divisional 2018-0040) |
GB201511191D0 (en) | 2015-06-25 | 2015-08-12 | Immatics Biotechnologies Gmbh | T-cell epitopes for the immunotherapy of myeloma |
ZA201707555B (en) | 2015-06-25 | 2018-11-28 | Immatics Biotechnologies Gmbh | Novel cell epitopes and combination of cell epitopes for use in the immuno-therapy of myeloma and other cancers |
GB201511546D0 (en) * | 2015-07-01 | 2015-08-12 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers |
EP3919507A3 (en) | 2015-07-01 | 2022-01-12 | Immatics Biotechnologies GmbH | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers |
HUE052628T2 (hu) * | 2015-07-06 | 2021-05-28 | Immatics Biotechnologies Gmbh | Új peptidek és peptidkombináció a nyelõcsõrák és más ráktípusok elleni immunterápiában történõ használatra |
GB201511792D0 (en) | 2015-07-06 | 2015-08-19 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against esopageal cancer and other cancers |
GB201512369D0 (en) | 2015-07-15 | 2015-08-19 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers |
MY198087A (en) | 2015-10-05 | 2023-07-31 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers |
GB201517538D0 (en) | 2015-10-05 | 2015-11-18 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers |
EP3167898A1 (en) | 2015-11-11 | 2017-05-17 | IEO - Istituto Europeo di Oncologia Srl | Method for obtaining tumor peptides and uses thereof |
CN109069604A (zh) * | 2016-02-22 | 2018-12-21 | 欧申赛德生物技术公司 | 新抗原组合物及其在免疫肿瘤治疗中的使用方法 |
SG11201808196UA (en) * | 2016-03-31 | 2018-10-30 | Neon Therapeutics Inc | Neoantigens and methods of their use |
TW202304970A (zh) * | 2016-08-26 | 2023-02-01 | 德商英麥提克生物技術股份有限公司 | 用於頭頸鱗狀細胞癌和其他癌症免疫治療的新型肽和支架 |
DE102016123893A1 (de) | 2016-12-08 | 2018-06-14 | Immatics Biotechnologies Gmbh | T-Zellrezeptoren mit verbesserter Bindung |
EP4317432A3 (en) | 2016-12-08 | 2024-04-17 | Immatics Biotechnologies GmbH | T cell receptors with improved pairing |
CN106986932A (zh) * | 2017-04-06 | 2017-07-28 | 海口市人民医院 | 一种c‑Met表位肽及其应用 |
US20210038703A1 (en) * | 2018-02-15 | 2021-02-11 | National University Corporation Asahikawa Medical University | Cancer Antigen Peptide |
CN110804642B (zh) * | 2019-09-10 | 2022-06-21 | 清华大学 | Gpr174免疫学功能及其用途 |
US20220387568A1 (en) * | 2019-11-14 | 2022-12-08 | Bogazici Universitesi | Asc specks in cancer immunotherapy |
CN114524870A (zh) * | 2020-11-23 | 2022-05-24 | 香雪生命科学技术(广东)有限公司 | 源自于ssx2抗原的短肽 |
EP4326325A1 (en) * | 2021-04-23 | 2024-02-28 | Flow Pharma Inc. | Vaccine for sars-cov-2 |
CN114478711A (zh) * | 2022-01-05 | 2022-05-13 | 成都朗谷生物科技股份有限公司 | 一种针对乙型肝炎病毒的抗原肽及其应用 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4440859A (en) | 1977-05-27 | 1984-04-03 | The Regents Of The University Of California | Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms |
US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
ES8105035A1 (es) | 1978-12-22 | 1981-05-16 | Biogen Nv | Un metodo para producir al menos un polipeptido que muestra antigenicidad de hbv |
US4530901A (en) | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
US4678751A (en) | 1981-09-25 | 1987-07-07 | Genentech, Inc. | Hybrid human leukocyte interferons |
US4766075A (en) | 1982-07-14 | 1988-08-23 | Genentech, Inc. | Human tissue plasminogen activator |
US4582800A (en) | 1982-07-12 | 1986-04-15 | Hoffmann-La Roche Inc. | Novel vectors and method for controlling interferon expression |
US4757006A (en) | 1983-10-28 | 1988-07-12 | Genetics Institute, Inc. | Human factor VIII:C gene and recombinant methods for production |
US4677063A (en) | 1985-05-02 | 1987-06-30 | Cetus Corporation | Human tumor necrosis factor |
US4810648A (en) | 1986-01-08 | 1989-03-07 | Rhone Poulenc Agrochimie | Haloarylnitrile degrading gene, its use, and cells containing the gene |
EP0671926B1 (en) * | 1992-08-11 | 2002-11-13 | President And Fellows Of Harvard College | Immunomodulatory peptides |
AUPM322393A0 (en) | 1993-12-24 | 1994-01-27 | Austin Research Institute, The | Mucin carbohydrate compounds and their use in immunotherapy |
WO1996003144A1 (en) | 1994-07-27 | 1996-02-08 | The Council Of The Queensland Institute Of Medical Research | Polyepitope vaccines |
DE69723230T2 (de) | 1996-01-17 | 2004-05-27 | Imperial College Innovations Ltd. | Immunotherapie mit verwendung von zytotoxischen t lymphozyten (ctl) |
US6096313A (en) * | 1996-02-09 | 2000-08-01 | Ludwig Institute For Cancer Research | Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant |
US6316213B1 (en) * | 1997-03-19 | 2001-11-13 | The Board Of Trustees Of The University Of Arkansas | Methods for the early diagnosis of ovarian, breast and lung cancer |
IL125608A0 (en) * | 1998-07-30 | 1999-03-12 | Yeda Res & Dev | Tumor associated antigen peptides and use of same as anti-tumor vaccines |
DE19917195B4 (de) | 1999-04-16 | 2006-09-28 | Immatics Biotechnologies Gmbh | Peptid zur Auslösung einer Immunreaktion gegen Tumorzellen, diese enthaltende pharmzeutische Zusammensetzungen, dessen Verwendungen, dafür codierende Nukleinsäure und diese Nukleinsäure enthaltender Expressionsvektor |
KR100358068B1 (ko) * | 1999-12-28 | 2002-10-25 | 주식회사 하이닉스반도체 | 플래쉬 메모리 소자의 제조방법 |
WO2004014867A2 (en) * | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
US20060045881A1 (en) * | 2004-08-26 | 2006-03-02 | Board Of Regents, The University Of Texas System | Anti-cancer vaccines |
-
2005
- 2005-09-05 PL PL05019255T patent/PL1760089T3/pl unknown
- 2005-09-05 DE DE602005016112T patent/DE602005016112D1/de active Active
- 2005-09-05 DK DK05019255T patent/DK1760089T3/da active
- 2005-09-05 AT AT05019255T patent/ATE440107T1/de active
- 2005-09-05 PT PT05019255T patent/PT1760089E/pt unknown
- 2005-09-05 EP EP05019255A patent/EP1760089B1/en not_active Not-in-force
- 2005-09-05 ES ES05019255T patent/ES2330013T3/es active Active
- 2005-09-05 SI SI200530796T patent/SI1760089T1/sl unknown
-
2006
- 2006-09-05 EP EP06777167A patent/EP1922334B1/en active Active
- 2006-09-05 AU AU2006289289A patent/AU2006289289B2/en not_active Ceased
- 2006-09-05 DK DK06777167.5T patent/DK1922334T3/da active
- 2006-09-05 SI SI200630949T patent/SI1922334T1/sl unknown
- 2006-09-05 CA CA2621414A patent/CA2621414C/en not_active Expired - Fee Related
- 2006-09-05 BR BRPI0615466-2A patent/BRPI0615466A2/pt not_active IP Right Cessation
- 2006-09-05 ES ES06777167T patent/ES2358802T3/es active Active
- 2006-09-05 WO PCT/EP2006/008641 patent/WO2007028573A1/en active Application Filing
- 2006-09-05 NZ NZ565956A patent/NZ565956A/en not_active IP Right Cessation
- 2006-09-05 UA UAA200803781A patent/UA97095C2/ru unknown
- 2006-09-05 RS RS20110146A patent/RS51893B/en unknown
- 2006-09-05 US US12/065,725 patent/US20090274714A1/en not_active Abandoned
- 2006-09-05 DE DE602006019446T patent/DE602006019446D1/de active Active
- 2006-09-05 UA UAA201111468A patent/UA105210C2/ru unknown
- 2006-09-05 KR KR1020087008126A patent/KR101150663B1/ko not_active IP Right Cessation
- 2006-09-05 JP JP2008528437A patent/JP5132561B2/ja not_active Expired - Fee Related
- 2006-09-05 CN CN200680038407.7A patent/CN101287755B/zh not_active Expired - Fee Related
- 2006-09-05 EA EA200800676A patent/EA013466B1/ru not_active IP Right Cessation
- 2006-09-05 PT PT06777167T patent/PT1922334E/pt unknown
- 2006-09-05 AT AT06777167T patent/ATE494303T1/de active
- 2006-09-05 PL PL06777167T patent/PL1922334T3/pl unknown
-
2008
- 2008-04-04 NO NO20081690A patent/NO20081690L/no not_active Application Discontinuation
-
2009
- 2009-10-08 CY CY20091101040T patent/CY1110536T1/el unknown
-
2011
- 2011-03-11 CY CY20111100271T patent/CY1113062T1/el unknown
- 2011-04-04 HR HR20110240T patent/HRP20110240T1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1922334T3 (da) | Tumorassocierede peptider, der binder til humant leukocyt antigen (HLA) klasse I eller II molekyler og dertil hørende anti-cancervaccine | |
DK2135878T3 (da) | Tumor-associerede peptider, der bindes promiskuøst til Humant Leukocyt-Antigen (HLA) klasse II molekyler |